JRCT ID: jRCT2080220485
Registered date:13/12/2007
Basic Information
Recruitment status | |
---|---|
Health condition(s) or Problem(s) studied | Patients that require long-term NSAID treatment to manage pain. |
Date of first enrollment | 13/12/2007 |
Target sample size | 602 |
Countries of recruitment | |
Study type | Interventional |
Intervention(s) | investigational material(s) Generic name etc : AG-1749 (Lansoprazole) INN of investigational material : Therapeutic category code : 232 Agents for peptic ulcer Dosage and Administration for Investigational material : Oral |
Outcome(s)
Primary Outcome | Frequency of gastric or duodenal ulcer |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | Not applicable |
---|---|
Age maximum | Not applicable |
Gender | Both |
Include criteria | 1) The patient was on NSAID treatment on the day when consent was obtained, and requires the long-term continuous treatment even after treatment with the investigational drug is started. 2) The patient was confirmed to have a history of gastric ulcer or duodenal ulcer (combined gastric and duodenal ulcer is also possible). |
Exclude criteria |
Related Information
Primary Sponsor | Takeda Pharmaceutical Company Limited |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) | JapicCTI-070495 |
Contact
Public contact | |
Name | |
Address | https://www.takeda.co.jp/contact/form/en/form/index.html |
Telephone | |
Affiliation | Takeda Phamaceutical Company Limited |
Scientific contact | |
Name | |
Address | |
Telephone | |
Affiliation |